MediXall Group, Inc.
MDXL
$0.0001
-$0.0038-97.44%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 304.30K | 330.90K | 349.60K | 309.40K | 235.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 304.30K | 330.90K | 349.60K | 309.40K | 235.10K |
| Cost of Revenue | 969.20K | 1.03M | 1.10M | 1.24M | 1.45M |
| Gross Profit | -664.80K | -698.70K | -747.20K | -932.20K | -1.21M |
| SG&A Expenses | 1.30M | 1.84M | 2.36M | 2.98M | 3.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -180.50K |
| Total Operating Expenses | 2.27M | 2.87M | 3.45M | 4.23M | 4.45M |
| Operating Income | -1.97M | -2.54M | -3.10M | -3.92M | -4.21M |
| Income Before Tax | -2.16M | -3.34M | -3.83M | -4.56M | -4.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.16 | -3.34 | -3.83 | -4.56 | -4.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.16M | -3.34M | -3.83M | -4.56M | -4.89M |
| EBIT | -1.97M | -2.54M | -3.10M | -3.92M | -4.21M |
| EBITDA | -1.94M | -2.51M | -3.07M | -3.88M | -4.17M |
| EPS Basic | -0.02 | -0.03 | -0.03 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.03 | -0.04 | -0.04 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 565.67M | 533.89M | 522.51M | 510.65M | 499.09M |
| Average Diluted Shares Outstanding | 565.67M | 533.89M | 522.51M | 510.65M | 499.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |